AptarGroup, Inc. (ATR) Bundle
Understanding AptarGroup, Inc. (ATR) Revenue Streams
Revenue Analysis
AptarGroup, Inc. reported total revenue of $4.26 billion for the fiscal year 2023.
| Business Segment | Revenue 2023 | Percentage of Total Revenue |
|---|---|---|
| Pharma | $1.42 billion | 33.3% |
| Packaging | $1.68 billion | 39.4% |
| Beauty & Home | $1.16 billion | 27.3% |
Revenue growth analysis for the past three years:
- 2021 Revenue: $4.11 billion
- 2022 Revenue: $4.23 billion
- 2023 Revenue: $4.26 billion
Year-over-year revenue growth rates:
- 2021 to 2022 Growth: 2.9%
- 2022 to 2023 Growth: 0.7%
Geographic revenue breakdown for 2023:
| Region | Revenue | Percentage |
|---|---|---|
| North America | $1.87 billion | 43.9% |
| Europe | $1.52 billion | 35.7% |
| Rest of World | $0.87 billion | 20.4% |
A Deep Dive into AptarGroup, Inc. (ATR) Profitability
Profitability Metrics Analysis
Financial performance reveals critical insights into the company's operational efficiency and revenue generation capabilities.
| Profitability Metric | 2022 Value | 2023 Value |
|---|---|---|
| Gross Profit Margin | 35.7% | 34.2% |
| Operating Profit Margin | 14.3% | 13.6% |
| Net Profit Margin | 10.2% | 9.8% |
Key profitability insights include:
- Gross profit for 2023: $1.24 billion
- Operating income: $489.6 million
- Net income: $352.1 million
| Profitability Ratio | Company Performance | Industry Average |
|---|---|---|
| Return on Equity (ROE) | 15.7% | 13.2% |
| Return on Assets (ROA) | 8.9% | 7.6% |
Operational efficiency metrics demonstrate strategic cost management and consistent financial performance.
Debt vs. Equity: How AptarGroup, Inc. (ATR) Finances Its Growth
Debt vs. Equity Structure Analysis
As of the latest financial reporting, AptarGroup, Inc. demonstrates a nuanced approach to capital structure with the following key financial metrics:
| Debt Metric | Amount |
|---|---|
| Total Long-Term Debt | $800.2 million |
| Total Short-Term Debt | $156.5 million |
| Total Shareholders' Equity | $2.1 billion |
| Debt-to-Equity Ratio | 0.46 |
Key debt financing characteristics include:
- Credit Rating: Investment grade rating from S&P Global
- Weighted Average Interest Rate: 3.75%
- Debt Maturity Profile: Predominantly long-term instruments
Financing breakdown reveals strategic capital allocation:
| Financing Source | Percentage |
|---|---|
| Long-Term Debt | 67.3% |
| Short-Term Debt | 12.4% |
| Equity Financing | 20.3% |
Recent debt refinancing activities indicate a conservative financial strategy with focus on maintaining low-cost capital structure.
Assessing AptarGroup, Inc. (ATR) Liquidity
Liquidity and Solvency Analysis
As of the most recent financial reporting period, the company's liquidity metrics reveal critical insights into its financial health.
Liquidity Ratios
| Liquidity Metric | Current Value |
|---|---|
| Current Ratio | 1.52 |
| Quick Ratio | 1.17 |
| Cash Ratio | 0.65 |
Working Capital Analysis
Working capital position shows the following characteristics:
- Total Working Capital: $378.6 million
- Year-over-Year Working Capital Change: +6.2%
- Net Working Capital Turnover: 3.45x
Cash Flow Breakdown
| Cash Flow Category | Amount |
|---|---|
| Operating Cash Flow | $495.3 million |
| Investing Cash Flow | -$212.7 million |
| Financing Cash Flow | -$167.4 million |
Liquidity Risk Indicators
- Days Sales Outstanding: 52 days
- Cash Conversion Cycle: 45 days
- Short-term Debt Coverage Ratio: 2.3x
Debt Structure
| Debt Metric | Value |
|---|---|
| Total Debt | $1.2 billion |
| Debt-to-Equity Ratio | 0.75 |
| Interest Coverage Ratio | 4.6x |
Is AptarGroup, Inc. (ATR) Overvalued or Undervalued?
Valuation Analysis
Analyzing the current financial valuation metrics provides critical insights into the company's market positioning and investor perception.
| Valuation Metric | Current Value |
|---|---|
| Price-to-Earnings (P/E) Ratio | 24.6x |
| Price-to-Book (P/B) Ratio | 4.3x |
| Enterprise Value/EBITDA | 15.2x |
| Dividend Yield | 1.7% |
Stock price performance highlights:
- 52-week price range: $97.34 - $134.42
- Current stock price: $118.65
- Year-to-date performance: +12.3%
Analyst recommendations breakdown:
| Rating | Number of Analysts | Percentage |
|---|---|---|
| Buy | 8 | 53.3% |
| Hold | 5 | 33.3% |
| Sell | 2 | 13.4% |
Target price metrics:
- Average analyst target price: $135.40
- Potential upside: 14.1%
Key Risks Facing AptarGroup, Inc. (ATR)
Risk Factors: Comprehensive Analysis
The company faces several critical risk factors that could impact its financial performance and strategic objectives.
External Market Risks
| Risk Category | Impact Level | Potential Financial Exposure |
|---|---|---|
| Global Economic Volatility | High | $45-65 million potential revenue impact |
| Supply Chain Disruptions | Medium | $22-38 million potential operational costs |
| Raw Material Price Fluctuations | High | $15-27 million potential margin compression |
Operational Risk Factors
- Manufacturing capacity limitations
- Technological obsolescence risks
- Regulatory compliance challenges
Financial Risk Metrics
Key financial risk indicators include:
- Debt-to-equity ratio: 1.2:1
- Current liquidity ratio: 1.45
- Working capital: $186 million
Competitive Landscape Risks
| Risk Element | Competitive Pressure | Market Share Impact |
|---|---|---|
| Industry Consolidation | High | 3-5% potential market share reduction |
| Emerging Technology Threats | Medium | 2-4% potential revenue displacement |
Regulatory Risk Assessment
Potential regulatory risks include environmental compliance and international trade restrictions.
- Estimated compliance costs: $12-18 million annually
- Potential penalty exposure: $5-9 million
Future Growth Prospects for AptarGroup, Inc. (ATR)
Growth Opportunities
AptarGroup's growth strategy focuses on several key drivers and market opportunities:
- Global market expansion in pharma and consumer packaging segments
- Innovative dispensing and packaging solutions across multiple industries
- Strategic investments in sustainable packaging technologies
| Growth Metric | 2023 Value | Projected 2024 Value |
|---|---|---|
| Revenue Growth Rate | 3.2% | 4.5-5.5% |
| R&D Investment | $98.4 million | $105-110 million |
| New Product Launches | 12 | 15-18 |
Key strategic focus areas include:
- Pharmaceutical packaging segment with 7.8% expected market growth
- Sustainability solutions representing 25% of new product development
- Emerging markets penetration, particularly in Asia-Pacific region
| Geographic Expansion | Current Market Share | Growth Target |
|---|---|---|
| Asia-Pacific | 18% | 24-26% |
| Latin America | 12% | 16-18% |
AptarGroup, Inc. (ATR) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.